Global Journal of Medical and Clinical Case Reports
Case Report
Angiokeratoma in Fabry Disease: Diagnostic but not Treatment Effectiveness Marker
Fabry disease (FD) is a rare X-linked recessive disorder caused by
mutations in the gene encoding the lysosomal enzyme α-galactosidase A (α
-Gal A). The resulting deficient α -Gal A activity leads to progressive
accumulation of glycosphingolipids, predominantly globotriaosylceramide
(GL-3) in the lysosomes of many different cell types throughout the
body [1]. The manifestations of this complex metabolic disease are
progressive and multysistemic, culminating in life-threatening renal,
cardiac and cerebrovascular manifestations [2].
http://www.peertechz.com/Clinical-Case-Reports/GJMCCR-1-112.php
Comments
Post a Comment